XML 41 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2022
Summary of Significant Accounting Policies [Line Items]        
Other income   $ 200 $ 3,556  
Company’s operations   The financial results of the Company’s operations are managed and reported to the Chief Executive Officer, who is considered the Company’s CODM, on a consolidated basis    
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]   Chief Executive Officer [Member]    
Mabwell (Shanghai) Bioscience Co., Ltd. [Member]        
Summary of Significant Accounting Policies [Line Items]        
Receivables       $ 3,500
Other income $ 3,500      
AbMed [Member]        
Summary of Significant Accounting Policies [Line Items]        
Ownership interest   82.00%    
Preferred Share [Member]        
Summary of Significant Accounting Policies [Line Items]        
Redemption price per share   $ 2